Dr. Emily Perdoncin, MD

Dr. Perdoncin practices at San Francisco Medical Center in San Francisco, California, part of Kaiser Permanente.

Dr. Perdoncin's NPI, 1740574557, was assigned on June 9, 2011. Dr. Perdoncin graduated from Geisel School of Medicine at Dartmouth in 2011. Dr. Perdoncin's Georgia license number on file is 86110.

Dr. Perdoncin's primary practice is San Francisco Medical Center, at 2425 Geary Blvd, San Francisco, CA 94115 in San Francisco County. The practice phone is (415) 833-2646.

Dr. Perdoncin's primary practice is San Francisco Medical Center in San Francisco, California, part of Kaiser Permanente. The medical group on file is The Permanente Medical Group, Inc. Dmand AI also links Dr. Perdoncin to 2 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Perdoncin practices, 3 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Perdoncin's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Perdoncin is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Perdoncin's licenses on file in 4 states: Georgia, California, Virginia and Michigan.

CMS data shows 18 Medicare services from Dr. Perdoncin across 1 procedure code in 2024, for 27 Medicare patients. Medicare paid $114 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 27 Medicare patients who saw Dr. Perdoncin in 2024. The largest group is 65 to 74, with 11 patients. 70% of them have high blood pressure, and 67% have high cholesterol. Their average risk score is 2.80, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Perdoncin's median patient age at 72, with 54% women.

In 2022, Dr. Perdoncin wrote 11 Medicare Part D claims. They cover 1 drug, with $9,309 in total drug cost. In 2020, CMS named 458 claims across 19 drugs.

Dr. Perdoncin accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 26 papers to Dr. Perdoncin, published from 2015 to 2024. 2022 was the busiest year, with 3. The most frequent topics are Transcatheter Aortic Valve Replacement, Aortic Valve Stenosis and Aortic Valve. Dr. Perdoncin has published most often in JACC Cardiovasc Interv. Dr. Perdoncin's most frequent co-authors are Vasilis C. Babaliaros, MD, Adam B. Greenbaum, MD and Kendra Janel Grubb, MD.

CMS Open Payments shows 173 general payments to Dr. Perdoncin from 30 drug and device companies from 2017 to 2025. Grants make up the largest share, 47% of the total. Medtronic Vascular, Inc. paid the most, $15,045.

Dr. Perdoncin graduated from Geisel School of Medicine at Dartmouth in 2011.

Dr. Perdoncin is in network with 6 carriers, including Aetna, Kaiser Permanente and HCSC. Medicare plans come from the most carriers, 3. Check the plan with the practice before a visit.